MMPP
MMPP is a novel VEGFR2 inhibitor with anti-inflammatory and potential anticancer activity, inhibits STAT3, inhibits angiogenesis via VEGFR2/AKT/ERK/NF-kappaB pathway, and can be used to alleviate myocardial injury.
Product Specifications
CAS Number
1895957-18-2
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
270.32
Molecular Formula
C17H18O3
Notes
Research use only, not for human use.
Receptor
STAT | VEGFR
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
RC212204L3 10 µg
AKAP14 (NM_001008535) Human Tagged Lenti ORF Clone
Sign In for Pricing
View Details 
MBS630279-01 10 Blots
Epidermal Growth Factor Receptor, phosphorylated (Tyr1148) (erbB, EGFR)
Sign In for Pricing
View Details MBS630279-02 5x 10 Blots
Epidermal Growth Factor Receptor, phosphorylated (Tyr1148) (erbB, EGFR)
Sign In for Pricing
View Details